Grace Therapeutics, Inc GRCE

Healthcare

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.

NDAQ:GRCE - Post by User

Grace Therapeutics, Inc

Bullboard Posts

Comment by Canadian_101on Nov 21, 2019 9:50am

89 Views

Post# 30377768

RE:RE:come on francine

Good for you Francine, well done, hope you enjoyed your dinner you deserve it.

Cheers

Hey boozer! I was missing my idiot friend.

I am all good, sold my 6 digits Amarin position last week with a significant profit. Tonight, I will enjoy a fancy diner sponsored my Amarin.

Didn't sold any of my 245,000 shares position with an average well below 1$ US. I am all good with the current market manipulation closed 2.78$ not dramatic, by friday we will be in the 3$Cdn range and next week Acasti will anonce the end of ph3 which bump the SP.

Also, don't forget Oppenheimer stated that Acasti have a superior product than Amarin. Which his always what i claimed :)

Enjoy the ride my friend. I hope your made a few dollars today :)

Bullboard Posts

AI companies to invest in